Petitioner To Board: Patented Glaucoma Treatment Is Invalid
ALEXANDRIA, Va. — In a March 14 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, a medical technology company says a single prior art reference...To view the full article, register now.
Already a subscriber? Click here to view full article